Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Red Tree Venture Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$81M
Portfolio companies 11
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.08
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Therapeutics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Red Tree Venture Capital:
Typical Co-investors
Red Tree Venture Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Red Tree Venture Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Advanced Fibre Communications (AFC) California, Petaluma, United States
C&B Capital Atlanta, Georgia, United States
Cyber Agent Ventures Beijing, Beijing, China
Fair/e France, Lyon, Rhone-Alpes
Headway Ventures De Pere, United States, Wisconsin
Industrial Alliance Securities Inc -
JCMB Beteiligungs Germany, Hamburg
KeyPlayers -
Lorinvest Brazil, Rio de Janeiro, Rio De Janeiro
Monestier Capital -
Nexus Medical Partners Massachusetts, Quincy, United States
Pi Labs England, London, United Kingdom
TOHO GAS Aichi Prefecture, Japan, Nagoya
Tracxn labs Bangalore, India, Karnataka
Upstream Ventures Central, Central Region, Singapore
Variant Alternative Income Fund -
Warren Citrin Impact Seed Fund -
WuXi PharmaTech China, Shanghai
Your Voice SPA -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

OWL

$157M19 Mar 2024 Bielefeld, Nordrhein-Westfalen, Germany

Bicara Therapeutics

Biopharma
Biotechnology
Health Care
Life Science
Therapeutics
$108M06 Mar 2023 Cambridge, Massachusetts, United States

CARGO Therapeutics

Biotechnology
Medical
Therapeutics
$200M01 Mar 2023 Palo Alto, California, United States

Rondo Therapeutics

Biopharma
Biotechnology
Health Care
Life Science
$67M02 Mar 2022 Hayward, California, United States

CARGO Therapeutics

Biotechnology
Medical
Therapeutics
01 Jan 2022 Palo Alto, California, United States

Magnus Medical

Health Care
Health Diagnostics
Medical
$25M28 Oct 2021 Burlingame, California, United States

Acrigen Biosciences

Biotechnology
Genetics
Life Science
28 Sep 2021 Berkeley, California, United States

Ceribell

Biotechnology
Health Care
Health Diagnostics
Medical Device
$53M29 Apr 2021 Mountain View, California, United States

Pipeline Therapeutics

Pharmaceutical
$80M11 Feb 2021 San Diego, California, United States
News
Magnus Medical Raises $25M in Series A Financing

– Magnus Medical, Inc. from Burlingame is developing non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.
– The company raised $25m in Series A funding.
– The round was co-led by Jazz Venture Partners and Red Tree Venture Capital.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Red Tree Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 12
Average round size 81M
Peak activity year 2021
Lead investments 3
Follow on index 0.08
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

OWL

$157M19 Mar 2024 Bielefeld, Nordrhein-Westfalen, Germany

Bicara Therapeutics

Biopharma
Biotechnology
Health Care
Life Science
Therapeutics
$108M06 Mar 2023 Cambridge, Massachusetts, United States

CARGO Therapeutics

Biotechnology
Medical
Therapeutics
$200M01 Mar 2023 Palo Alto, California, United States

Rondo Therapeutics

Biopharma
Biotechnology
Health Care
Life Science
$67M02 Mar 2022 Hayward, California, United States

CARGO Therapeutics

Biotechnology
Medical
Therapeutics
01 Jan 2022 Palo Alto, California, United States

Magnus Medical

Health Care
Health Diagnostics
Medical
$25M28 Oct 2021 Burlingame, California, United States

Acrigen Biosciences

Biotechnology
Genetics
Life Science
28 Sep 2021 Berkeley, California, United States

Ceribell

Biotechnology
Health Care
Health Diagnostics
Medical Device
$53M29 Apr 2021 Mountain View, California, United States

Pipeline Therapeutics

Pharmaceutical
$80M11 Feb 2021 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: